Biosimilar Drug Development World Europe 2017

Topics

• Realistic business opportunities and hurdles to biosimilars industry
• Approaches and opportunities in partnering to aid biosimilars development and commercialization
• Solutions to some of the unique challenges associated with biosimilar product and process development

Who should Attend

Senior Directors & Heads in the following departments:

• Development
• Formulation
• Clinical Trials
• Regulatory Affairs
• Preclinical Dev
• Pharmacovigilance
• Manufacturing
• Toxicology
• CMC
• Bioequivalence